Revenue: The sum of all revenue fields included for a company's operating activities.
RVL Pharmaceuticals PLC (RVLP) had Revenue of $8.26M for the most recently reported fiscal quarter, ending 2023-06-30.
| Income Statement Financials | |
|
Revenue |
$8.26M |
$-23.89M |
|
$1.95M |
|
$6.31M |
|
$30.28M |
|
$-22.02M |
|
$-1.98M |
|
$-24.00M |
|
$-24.00M |
|
$-23.89M |
|
$-23.89M |
|
$-23.89M |
|
$-23.89M |
|
$-22.02M |
|
$-8.03M |
|
99.37M |
|
99.37M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$25.75M |
|
$3.44M |
|
$59.65M |
|
$85.40M |
|
$68.39M |
|
$0.01M |
|
$0.69M |
|
$69.08M |
|
$16.33M |
|
$-39.52M |
|
$16.33M |
|
99.39M |
|
| Cash Flow Statement Financials | |
$-17.88M |
|
$-2.18M |
|
$-5.32M |
|
$44.54M |
|
$19.16M |
|
$-25.38M |
|
$0.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.38 |
|
-- |
|
-- |
|
0.00 |
|
3.54 |
|
76.44% |
|
-266.66% |
|
-266.66% |
|
-- |
|
-290.65% |
|
-289.28% |
|
$-20.06M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
1.44 |
|
4.27 |
|
21.06 |
|
-146.32% |
|
60.45% |
|
-27.97% |
|
-146.22% |
|
$0.16 |
|
$-0.20 |
|
$-0.18 |
|